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Are women ready for the new cervical screening protocol in
England? A systematic review and qualitative synthesis of views
about human papillomavirus testing
M Hendry*,1, D Pasterfield1, R Lewis1, A Clements2, S Damery3, RD Neal1, R Adke4, D Weller5, C Campbell5,
J Patnick6, P Sasieni7, C Hurt8, S Wilson3 and C Wilkinson1
1North Wales Centre for Primary Care Research, Bangor University, Gwenfro Units 4-8, Wrexham Technology Park, Wrexham LL13 7YP, UK;
2Department of Primary Care Health Sciences, University of Oxford, 2nd Floor, 23-38 Hythe Bridge Street, Oxford OX1 2ET, UK; 3School of Health &
Population Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK; 4The Surgery, Pierce Street, Queensferry, CH5 1SY, UK; 5Centre for
Population Health Sciences, University of Edinburgh, Teviot Place, Edinburgh, EH8 9AG, UK; 6NHS Cancer Screening Programmes, Fulwood House,
Old Fulwood Road, Sheffield, S10 3TH, UK; 7Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Charterhouse Square, London
EC1M 6BQ, UK; 8Wales Cancer Trials Unit, 6th Floor, Neuadd Meirionnydd, University Hospital of Wales, Heath Park, Cardiff CF14 4YS, UK
BACKGROUND: A new protocol for human papillomavirus (HPV) testing within the UK cervical screening programme commenced in
April 2011, creating new patient experiences. This is the first review to synthesise a substantial body of international evidence of
women’s information needs, views and preferences regarding HPV testing. We aimed to inform the development of educational
materials to promote informed choice, reduce anxiety and improve disease control.
METHODS: We searched 12 bibliographic databases. Two reviewers independently screened papers and assessed study quality;
disagreements were resolved by discussion. Results were extracted verbatim and authors’ findings treated as primary data. Studies
were synthesised collaboratively using framework methods.
RESULTS: We synthesised findings from 17 studies. Women had overwhelmingly negative concerns; an HPV diagnosis was daunting,
had associated problems of disclosure of a sexually transmitted infection (STI), impacted on relationships and provoked fear of
stigmatisation. Nevertheless, many thought HPV testing could be a preferable alternative to repeat cytology. Knowledge was poor;
women struggled to interpret limited information in the context of existing knowledge about STIs and cervical cancer.
CONCLUSION: Women are likely to be poorly informed, have limited understanding and many unanswered questions. This could
increase anxiety and reduce ability to make informed choices, presenting a substantial challenge for those who design and provide
information.
British Journal of Cancer (2012) 107, 243–254. doi:10.1038/bjc.2012.256 www.bjcancer.com
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High-risk human papillomavirus (HPV) types 16 and 18 account
for 70% of cervical cancers. England’s NHS Cervical Screening
Programme was the first in the United Kingdom to launch a new
protocol of HPV triage in April 2011 (Department of Health, 2011).
Women with borderline or mild dyskaryosis will be routinely tested
for HPV, and triaged according to the results (Figure 1; NHS Cancer
Screening Programmes, 2010). High-risk human papillomavirus
test-positive women will be fast-tracked to colposcopy, replacing
usual practice of cytological surveillance at six monthly intervals.
HPV test-negative women, deemed low risk for cervical cancer, will
return to routine age-sensitive screening rather than cytological
surveillance (Figure 1; NHS Cancer Screening Programmes, 2010;
NHSCSP, 2010). These new clinical pathways generate new patient
experiences. Acceptability to women is likely to be closely related
to knowledge and understanding; poor understanding of test
results is associated with anxiety (Maissi et al, 2004).
Both the natural history of HPV and this new protocol are
complex. To achieve good uptake in cervical cancer prevention
while adequately informing women, HPV information should be
evidence-based, sensitive to UK culture and practice, with accurate
risk/benefit portrayal and estimation of uncertainty and con-
sequences (Barratt et al, 2004; Bekker, 2010). This systematic
review aimed to synthesise qualitative and quantitative evidence of
people’s information needs, views and preferences regarding HPV
testing, to inform the development of HPV educational materials
to promote the key outcomes of informed choice, minimal anxiety
and adequate uptake needed for disease control.
MATERIALS AND METHODS
The review was conducted using methodology reported in the NHS
Centre for Reviews and Dissemination report 4 (NHS Centre for
Reviews and Dissemination, 2001), supplemented by Harden’s
recommendations for systematic reviews of qualitative studies
(Harden et al, 2004). We also adhered to guidance on methods
for conducting and reporting systematic reviews in the PRISMA
*Correspondence: Dr M Hendry; E-mail: m.hendry@bangor.ac.uk
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statement, where it could be applied to reviews of qualitative
studies (Moher et al, 2009).
We searched 12 electronic databases using thesaurus terms and
keywords relating to HPV and vaccination or testing (Appendix 1).
Bibliographies of included studies were hand-searched. Searches
were conducted in June 2009, updated in July 2010, and limited to
1980 onwards, when relevant papers began to appear. Two (of
three) reviewers (MH, RL and DP) independently screened titles
and abstracts for relevance, assessed relevant papers against
inclusion criteria and considered study quality. Disagreements
were resolved by discussion. Inclusion and exclusion criteria are
detailed in Table 1.
Qualitative studies were appraised using a quality checklist
(National Institute for Health and Clinical Excellence, 2009).
We excluded quotations from the original data and treated
authors’ findings as primary data. Synthesists differ on what
counts as data from primary studies (Major and Savin-Baden,
2010). We considered authors’ findings to be syntheses of entire
primary data-sets, whereas quotations were illustrative examples
of specific points. Studies were synthesised collaboratively by
two reviewers (MH and DP) using the framework approach
(Ritchie and Spencer, 1994). Data were repeatedly read to achieve
familiarity, themes were identified and organised into categories,
reviewed and refined until both reviewers agreed on the validity of
the thematic framework. Data were then coded, the framework
applied and again reviewed and refined until consensus was reached
(Swallow et al, 2003).
Surveys were assessed using a quality checklist adapted from
Pettigrew and Roberts (2006), and summarised using narrative
synthesis methods (Popay et al, 2006).
RESULTS
Summary of included studies
Sixteen surveys or qualitative studies and one mixed method
(qualitative and quantitative) study (data from this study are
Routine 3 or 5 year
recall
(depending on age
<50 or >50)
Borderline or
mild
diskaryosis
Colposcopy
no repeat
cytology
HPV– HPV+
CIN1
No treatment
Cytology at 12 months with or
without colposcopy
(local preference)
Routine 3 or 5 year
recall
(depending on age
<50 or >50)
Borderline/
mild with
negative
colposcopy,
no biopsy or
biopsy with no
CIN
Moderate or
worse with
treated CIN
CIN2/3
Cytology at 6
months
HPV– HPV+
Colposcopy and
cytology
follow-up according to
national guidelines
Treatment
Repeat cytology
at 6 and 12
months
Colposcopy
Return to routine recall
after 2 years negative
post-treatment cytology
Follow-up for at least 10
years according to
national guidelines
Cytology at 6
months
Normal Abnormal
Routine 3 or 5 year
recall
(depending on age
<50 or >50)
Normal Abnormal
Figure 1 Cervical screening protocols before and after the introduction of HPV testing.
Table 1 Inclusion and exclusion criteria for studies of HPV testing
Inclusion Exclusion
Population Any participants who are asked about HPV testing in the context
of either hypothetical scenarios or personal experience of testing
Intervention HPV testing in the context of cervical screening Studies about HPV infection, or cervical screening, not HPV testing
Studies about the testing process, for example, self-sampling versus conventional methods
Outcomes People’s views on HPV testing, such as their understanding,
attitude, perception, acceptability, concerns and information needs
Studies that assess participants’ knowledge and/or behaviour, not their views
Study design Any study design used to elicit qualitative or quantitative
data relating to participants’ views about HPV testing
Reporting Studies must be reported in sufficient detail for meaningful
data extraction
Studies with insufficient detail, for example, available only as abstracts
Abbreviation: HPV¼ human papillomavirus.
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reported with qualitative and quantitative results, therefore it may
appear to be counted twice) met our inclusion criteria (Figure 2).
Publication dates ranged between 1997 and 2010; most recent
data collection reported in May 2007; thus most studies reflect
findings that predate HPV vaccination and associated public
information.
Qualitative studies Eleven qualitative studies were included
(Table 2). Studies reporting results in more than one publication
(Kahn et al, 2007; Daley et al, 2010) were consolidated. Included
studies were from United States, United Kingdom, Australia and
Canada and all used either focus groups or face-to-face interviews.
Methods of analysis were grounded theory, thematic analysis or
framework. Most recruited adult women; the majority of
participants reflected UK cervical screening age. Study details are
fully described in Table 2.
In five studies smear and HPV tests were conducted and results
were known at the time of interview (McCaffery and Irwig, 2005;
McCaffery et al, 2006; Kahn et al, 2007; Waller et al, 2007b; Daley
et al, 2010). In two of these, participants had mixed results: HPV
positive and negative; cytology normal and abnormal (McCaffery
et al, 2006; Kahn et al, 2007). In two studies all were HPV positive
and had abnormal cytology (McCaffery and Irwig, 2005; Daley
et al, 2010). In one, all were HPV positive but had normal cytology
(Waller et al, 2007b), in this study participants were retested after
12 months and, if still HPV positive, offered the choice of retest
after a further 12 months or immediate colposcopy. Six studies
gave untested women information about HPV then sought views
about HPV testing (McCaffery et al, 2003; Anhang et al, 2004;
Brown et al, 2007; Vanslyke et al, 2008; Fernandez et al, 2009;
Marlow et al, 2009).
Surveys Seven surveys, from the United States, Australia and
Canada, met our inclusion criteria (Table 3). Sample sizes ranged
from 50 to 968. Four studies included participants with abnormal
cytology. In one of these, participants were HPV positive (Daley
et al, 2010), in three their HPV status was unknown (Le et al, 2004;
McCaffery et al, 2008; Patel et al, 2008). In the remaining three
studies, convenience samples of women were surveyed and
selection criteria, if any, related to age, gender or ethnicity
(Ferris et al, 1997; Huang et al, 2008; Papa et al, 2009).
Study quality
All included qualitative studies were considered by two reviewers
to be of good to moderately good standard (Table 4). Only one
survey was deemed to be good quality, that is, well conducted with
a large sample size (4500) and high response rate (480%; Huang
et al, 2008; Table 5).
Evidence synthesis
Three main categories (and themes within them) emerged from the
included studies.
The psychosocial burden of HPV infection
Emotional responses to diagnosis Nine qualitative studies
described participants’ emotional reactions to receiving an HPV
diagnosis, either in reality (McCaffery and Irwig, 2005; McCaffery
et al, 2006; Kahn et al, 2007; Waller et al, 2007b; Daley et al, 2010)
or in response to hypothetical questions (McCaffery et al, 2003;
Anhang et al, 2004; Vanslyke et al, 2008; Fernandez et al, 2009). All
reported emotions such as worry, fear, anger, distress, anxiety,
upset, shock and confusion. In one study a negative test result,
following a previous positive result, was associated with feelings of
relief or happiness (Waller et al, 2007b). Some participants found
awareness of their HPV status reassuring or empowering
(McCaffery et al, 2003; Anhang et al, 2004; Kahn et al, 2007;
Vanslyke et al, 2008), because, if positive, they felt they could do
something about it.
Womeny characterised the HPV test result as a three-part
negative diagnosisythey find out that (1) they have an
abnormal result, (2) a sexually transmitted disease that is not
curable and (3) a condition that may progress to cancer. (Daley
et al, 2010)(USA, abnormal cytology, all HPVþ )
A number of participants, particularly those with abnormal
result, believed that early discovery of an abnormal test result
enabled them to take action to prevent later disease. (Kahn et al,
2007) (USA, all tested, 23% abnormal cytology, 51% HPVþ )
Three USA surveys reported emotional reactions to HPV test
results; two of these had small samples and all three had a low or
unreported response rate. In one all participants had abnormal
cytology and were HPV positive (Daley et al, 2010). Negative
responses included stigma (71%), anxiety (94%), stress (95%),
anger (70%), confusion (71%), shock (70%) and self-blame (68%);
26% thought their HPV test results could change their future
pregnancy plans. However, there were also positive responses: 95%
agreed that ‘it could be worse’, 63% were ‘hopeful’, 68% felt ‘in
control’ and 20% ‘empowered’. For women attending a primary
care clinic for their annual smear test, concern about testing
positive for HPV decreased from 60 to 27% following an
Records identified through
database searching
(n = 23 010)
Records after duplicates
removed
Records excluded
(n =8972)
Records screened
(n = 9319)
Articles excluded
(n = 241)
Excluded intervention (n =51)
Excluded population (n =36)
Excluded outcomes (n =90)
Excluded study design (n =15)
Unobtainable (n =24)
Insufficient data (n =25)
Articles assessed for
eligibility
(n = 347)
Studies included
(n =92)
(106 articles)*
Studies on HPV
vaccination
(n =75)
(87 articles)
Studies on HPV
testing
(n = 17)
(19 articles)
Qualitative
studies
(n = 10)
(11 articles)
Surveys
(n = 6)
(6 articles)
Records identified through
hand searches
(n = 4)
Mixed
method
studies
(n =1) 
(2 articles)
Figure 2 PRISMA flowchart. *Some studies were reported in more than
one publication. wData from this study are reported with qualitative and
quantitative results as appropriate.
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educational intervention but concern about a future diagnosis of
cervical cancer increased slightly (Papa et al, 2009). Of 202 women
surveyed in a colposcopy clinic, 87% felt that knowing their HPV
status made them feel less nervous (Patel et al, 2008).
Anxiety associated with HPV-positive status In four qualitative
studies, specific worries for those who had received a positive HPV
test result included possible transmission to a partner, risk of
cervical cancer, impact on sexual relationships and fertility, and
fear of stigma and blame (McCaffery and Irwig, 2005; McCaffery
et al, 2006; Waller et al, 2007b; Daley et al, 2010).
These (feelings) included fear and anxiety about cancer and
becoming ill, concerns about fertility, feelings of being unclean
because of the sexually transmitted nature of HPV, concerns
about transmission and sexual relationships, a negative impact
on feelings about sex, and relationship issues including blaming
a partner for the infection. (Waller et al, 2007b) (UK, normal
cytology, all HPVþ at baseline)
Six qualitative studies described worry about the definition of
HPV as an sexually transmitted infection (STI; Anhang et al, 2004;
McCaffery and Irwig, 2005; McCaffery et al, 2006; Brown et al,
2007; Kahn et al, 2007; Daley et al, 2010). For many participants,
especially in specific ethnic and religious groups (South Asian,
Hispanic, Roman Catholic), associations with promiscuity and
immoral behaviour led to feelings of stigma, shame and
embarrassment, and potentially grave consequences.
They associated stigma with sexual transmission, linking HPV
transmission to infidelity, immorality and degenerate beha-
viour. They clearly anticipated extreme [psychological] discom-
fort if informed of having positive test results. (Brown et al,
2007) (Canada, hypothetical)
Table 2 Included qualitative studies
Study, Location
Data collection method
and date Participant detailsa Analysis
Type of data collected or relevant questions
asked
Anhang, 2004
Massachusetts, USA
Focus groups based on brief
description of HPV
August/September 2002
48 women aged 18–55þ (years) from low-income
and minority populations; 44% Hispanic, 40% white;
73% educated to high school level
or less
Grounded
theory
Topics included current level of HPV knowledge, what
information they would like to receive, how they
imagined it would feel to receive a positive HPV test
result, and whether they would like to
be tested
Brown, 2007
Ontario, Canada
Face-to-face interviews based
on HPV information and case
scenario
Date not reported
20 women aged 25–83– a random sample of adult
females in Ontario
65% Had college or university education
Thematic
analysis
Women were asked views on four different treatment
options for a case scenario of abnormal cytology:
colposcopy; repeat Pap test; HPV test; discuss with
primary care physician
Daley, 2010
Urban and rural
South East, USA
Face-to-face interviews based
on experience of HPV testing
October 2001–September
2005
52 women recruited in gynaecological clinics, aged
18–44 years, who had abnormal cytology and were
HPV positive
75% White, 11% Hispanic
Thematic
analysis
Topic guide included knowledge of HPV, emotional
responses to diagnosis, disclosure of test results and
changes in health behaviour
Fernandez, 2009
Brownsville,
TX, USA
Focus groups based on case
scenario 2005
41 Hispanic adults aged 19–76 years (30 female)
recruited in a poor area with high rates of
cervical cancer
Thematic
analysis
Topic guide included HPV awareness, knowledge and
attitudes
Reactions to learning about an HPV diagnosis were based
on scenarios of a woman hearing her Pap test result,
HPVþ status and disclosing her status to her partner
Kahn, 2007
Cincinnati,
OH, USA
Baseline questionnaire followed
by face-to-face interview 2
weeks later on receipt of test
results
July 2002/January 2003
Sexually active females aged 14–21, recruited in an
urban teen health centre
51% HPV positive, 23% abnormal cytology
82% non-Hispanic Black
Framework Two topic guides used: one emphasised personal
meaning of test results (perception of risk, personal
liability etc), a second was modified to focus on cognitive
understanding of test results and personal experience of
STIs and cancer
Marlow, 2009
London, UK
Face-to-face interviews based
on brief information about HPV
Date not reported
21 women aged 18–53 years recruited in a University
setting by ‘snowballing’.
95% White British
76% had university education.
Framework Women were asked what information they would need
to be sufficiently informed to make a decision about HPV
testing
McCaffery, 2003
Greater Manchester,
UK
Eight focus groups based on
brief information about HPV
and HPV testing
July/September 2000
71 women aged 20–59 years; 28% Pakistani, 27%
Indian, 22% African-Caribbean, 22% White British;
35% had some tertiary education; 76% of these were
Indian or Pakistani
Framework Topic guide focused on reactions to HPV as an STI linked
to cervical cancer; anticipated reactions to testing positive
for HPV; partner, family and community attitudes to HPV
testing, and religious and cultural influences
McCaffery, 2005
Sydney & surrounds,
Australia
Face-to-face interviews based
on experience of testing
June/December 2002
20 women of screening age who were HPV positive
and had abnormal cytology.
68% Anglo-Australian.
47% Had tertiary education.
Framework Topic guide covered issues relating to the diagnosis of
HPV and cervical screening, women’s psychological
response to their HPV infection, their understanding of
HPV and their information needs and preferences
McCaffery, 2006
Manchester &
London, UK
Face-to-face interviews based
on experience of testing
June 2001/December 2003
74 women aged 20–64 years recruited in clinical trials
of HPV testing or colposcopy clinics
54% Abnormal cytology, 77% HPV positive
55% White, 23% South Asian, 22% African-
Caribbean. 61% had tertiary education
Framework Topic guide included screening history, understanding of
HPV test, experience of smear test results and HPV
diagnosis, understanding and disclosure of results,
emotional impact, and experience of treatment or follow-
up
Vanslyke, 2009
Albuquerque,
NM, USA
Focus groups based on brief
information about HPV and
HPV testing ‘before vaccine
publically available’
54 low-income Hispanic women aged 18–60 years
recruited in community locations; 43% had only
primary education; 63% had household income
o$20 000
Thematic
analysis
Topic guide included questions about cervical cancer and
HPV, how participants would feel about being tested for
HPV, and which of the three HPV prevention options
they preferred and why:
(1) fewer sexual partners; (2) condoms; and
(3) vaccines
Waller, 2007b
Manchester, UK
Face-to-face interviews
following a second (12 month
follow-up) HPV test
Date not reported
30 women aged 20–50þ (years), HPV positive with
normal cytology at baseline; some HPV positive and
some negative at 12 month follow-up; 47% had
tertiary education
Framework Topic guide focused on emotional responses to the tests,
differences between the impact of the two tests,
disclosure of results, decisions about follow-up and feeling
about future screening
Abbreviations: HPV¼ human papillomavirus; STI¼ sexually transmitted infection. aAge range, ethnicity, educational level and indicators of socio-economic status are given
where data are available.
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There were also similarities between the South Asian
group and the white British and African Caribbean women
with strong religious beliefs. Among these women there
was some existing stigma around an abnormal smear,
and a direct link with sexual activity and promiscuity.
(McCaffery et al, 2006) (UK, all tested, 54% abnormal cytology,
77% HPVþ )
However, one small US survey of a mainly white population tests
reported that, following an educational intervention, participants
did not feel particularly anxious about getting tested for HPV and
were very likely to agree to it (Papa et al, 2009).
The effect of HPV diagnosis on relationships The effect of an HPV
diagnosis on relationships was explored in seven qualitative
Table 3 Included surveys
Study,
location Setting
Data
collection
method,
date and
response
rate Participant detailsa Summary of relevant questions Summary of results
Daley, 2010
South East,
USA
Routine annual
gynaecological
examinations in local
clinics
Paper and
pencil
questionnaire
administered
in clinic
October
2001/
September
2005
RR 31%
154 women aged 418 years with
abnormal cytology
and HPVþ 69% White,
16% Hispanic
HPV knowledge, disclosure of HPV test results,
emotional impact of HPV diagnosis
Only 39% correctly understood their own HPV
diagnosis. 93% had disclosed their HPV status, 39%
to a partner; 66% would disclose it to a future
partner. 82% sought information from the internet,
70% from other sources. Negative responses
included stigma (71%), anxiety (94%), stress (95%),
anger (70%), confusion (71%), shock (70%) and
self-blame (68%) but 95% agreed it could be
worse. 26% thought HPV test results could change
their future pregnancy plans
Ferris, 1997
Augusta,
GA, USA
Waiting rooms in one
civilian and one military
family practice clinic and
one obs and gynae clinic
Questionnaire
self-completed
in clinic
Date not
reported
RR 99%
968 women aged416 years; 55%
black; 29% family income o$25K,
10% 4$50K; 11% did not
complete high school;
19% had tertiary education
Management preferences for case scenarios of
ASCUS or LSIL based on test accuracy, potential
discomfort and cost
Case
scenario
Management preference
Repeat
smear
test (%)
Cervicography
or colposcopy
(%)
HPV
DNA
test
(%)
ASCUS 68 35 7
LSIL 14 78 8
Test accuracy was the primary reason for women’s
choice.
Huang,
2008
San
Francisco,
USA
University based and
community based
primary care practices
and community health
clinics
Telephone and
face-to-face
interviews
October
2002/January
2006
RR 85%
865 women aged 50–80 years;
43% Asian, 30% White, 17%
Latina; 39% did not complete high
school;
31% income o$15 000
Awareness of HPV and previous HPV testing;
desire for HPV test; desired frequency of smear
tests if HPV test was positive
30% had heard of HPV and 7% had had an HPV
test; 64% wanted to be tested for HPV. However,
78% would want frequent smear tests (41 annually)
if tested positive.
55% of women aged o65 years thought three
yearly smear tests acceptable if HPV negative with
normal cytology and 33% of women aged X65
years would stop getting smear tests if HPV negative
(þ 19% if physician recommended)
Le, 2004
Ottawa,
Canada
University colposcopy
clinic
Face-to-face
interviews
Date not
reported
RR 75%
100 women aged 18–75 years,
42% with minor abnormal
cytology; 66% office workers with
tertiary education; 20% manual
workers
Knowledge of the role of HPV in CIN and the
rationale behind HPV testing; preferences
between six monthly colposcopy (standard
practice) or HPV test and annual colposcopy if
HPV negative
75% had little or no knowledge about the role of
HPV in CIN; 84% had never heard of the HPV test,
or had minimal knowledge. After explanation, 64%
chose an HPV test with less frequent colposcopy
follow-up if negative rather than six monthly
colposopic surveillance until
two consecutive clear results were obtained
McCaffery,
2008
Throughout
Australia
Cervical screening
in urban and rural family
planning clinics across
Australia
Postal
questionnaires
Date not
reported
RR 89%
106 women aged 16–70 years
with minor abnormal cytology;
42% university graduates
After using a decision aid, women chose their
preferred management for mildly abnormal
cytology:
(1) HPV test; (2) usual care
(a repeat smear test)
Of the 94 women who made a management
choice 65% chose to have HPV testing. Having
children, having a previous abnormal smear and
having higher distress scores were significantly
associated with choosing HPV triage
Papa, 2009
MA, USA
Routine annual
examinations in
one university hospital
based obs and gynae
clinic
Questionnaire
self-completed
in clinic
January–March
2007
RR not
reported
50 women aged 30–69
years, 50% with history of
abnormal cytology; 14% HPV; 88%
white; 72% had tertiary education
Questions asked pre- and post-educational
intervention: knowledge of HPV, pap smears
and cervical cancer; feelings about being tested
for HPV; concerns if tested positive; acceptability
of HPV testing
10 of the 16 knowledge questions were answered
correctly significantly more often after the
education intervention. Concern about testing
positive to HPV decreased from 60% to 27% after
education but the most common concern, a future
diagnosis of cervical cancer, increased slightly.
Women did not feel particularly anxious about
getting tested for HPV and were very likely to
agree to it
Patel, 2008
Pittsburgh,
PA, USA
Hospital
colposcopy clinic
serving mainly low-
income women
Questionnaire
distributed in
clinic
January–May
2007
RR not
reported
202 women aged 418
years, 58% had 41 colposcopy
visit; 58% white; 38% black; 41%
high school education or less
Knowledge of HPV; preferred follow-up strategy
after a diagnosis of CIN1:
(1) smear test at 6 and 12 months
(2) HPV test at 12 months
75% knew what HPV or the HPV test was; 40%
knew HPV is associated with warts, abnormal
smears, cervical cancer, and 65% that it is sexually
transmitted. 87% felt knowing their HPV status
made them feel less nervous and 67% would feel
less nervous if they could have less frequent
smears. However, 64% preferred follow-up to be a
smear test at 6 and 12 months, rather than an HPV
test in 1 year
Abbreviations: ASCUS¼ atypical squamous cells of undetermined significance; CIN¼ cervical intraepithelial neoplasia; HPV¼ human papillomavirus; LSIL¼ low-grade squamous
intraepithelial lesion; RR¼ response rate. aAge range, ethnicity, educational level and indicators of socio-economic status are given where data are available.
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Table 4 Quality assessment of qualitative studies
Anhang,
2004
Brown,
2007
Daley,
2010
Fernandez,
2009
Kahn,
2007
Marlow,
2003
McCaffery,
2003
McCaffery,
2005
McCaffery,
2006
Vanslyke,
2009
Waller,
2007b
Theoretical approach
1.1 Is a qualitative
approach appropriate?
Appropriate | | | | | | | | | | |
Inappropriate
Unsure
1.2 Is the study clear in
what it seeks to do?
Clear | | | | | | | | | | |
Unclear
Mixed
Study design
2.1 How defensible/
rigorous is study design/
methodology?
Defensible | | | | | | | | | |
Not defensible
Unsure |
Data collection
3.1 How well was data
collection carried out?
Appropriate | | | | | | | | | |
Inappropriate
Unsure/ unclear |
Validity
4.1 Is researcher’s role
clearly described?
Clear |
Unclear
Not described | | | | | | | | | |
4.2 Is context clearly
described?
Clear | | | | | | | | |
Unclear | |
Unsure
4.3 Were methods
reliable?
Reliable | | | | | | | | |
Unreliable
Unsure | |
Analysis
5.1 Is data analysis
sufficiently rigorous?
Rigorous | | | | | | | | | | |
Not rigorous
Unsure/unreported
5.2 Are the data ‘rich’?
Rich | | | | | | | | |
Poor
Poorly reported | |
5.3 Is the analysis
reliable?
Reliable | | | | | | | |
Unreliable
Unsure/unreported | | |
5.4 Are findings
convincing?
Convincing | | | | | | | | | | |
Not convincing
Unsure
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studies, four relating to real situations (McCaffery et al, 2006;
Kahn et al, 2007; Waller et al, 2007b; Daley et al, 2010)
and three to hypothetical questions (McCaffery et al, 2003;
Vanslyke et al, 2008; Fernandez et al, 2009). In response
to hypothetical situations, both men and women would worry
that their partner had been unfaithful or that they themselves
would be accused of infidelity. They were concerned about
the effect this would have on their relationship, particularly
if there were already relationship problems. For women who
had received HPV positive test results, similar concerns were
expressed and appeared to be connected with participants’
assumptions that the infection must have come from a current
or recent partner.
y in relationships where there had been recent discord,
infidelity, or had ended unhappily, the HPV test result led to
questions about trust and fidelity and accusations of blame
for the infection. (McCaffery et al, 2006) (UK, all tested, 54%
abnormal cytology, 77% HPVþ )
Most women said that their partner would be angry, doubt their
fidelity, and possibly abandon them... While some men under-
stood that their own infidelity could be the cause of their
partner’s infection, most stated that their first reaction would be
to question the woman’s faithfulness. (Fernandez et al, 2009)
(USA, hypothetical)
In two qualitative studies, where participants realised that HPV
infection could lie dormant for a considerable period and therefore
could have been acquired from their own or their partners’
previous relationships, less anxiety was expressed (McCaffery
et al, 2006; Waller et al, 2007b). Failure to understand this led
participants to believe that the test was a reliable method of
establishing fidelity (McCaffery et al, 2003; Kahn et al, 2007). None
of the included surveys addressed this theme.
Particularly reassuring was the knowledge that the virus could
lie dormant for a long time so exposure was not necessarily
recent and did not mean that a partner had been unfaithful.
(Waller et al, 2007b) (UK, normal cytology, all HPVþ at baseline)
An unexpected finding was the frequency with which partici-
pants noted that testing was an effective way to monitor
one’s sexual partners. (Kahn et al, 2007) (USA, all tested, 23%
abnormal cytology, 51% HPVþ )
Participants were divided about feelings of guilt relating to a
positive HPV diagnosis. Some women considered themselves at
Table 4 (Continued )
Anhang,
2004
Brown,
2007
Daley,
2010
Fernandez,
2009
Kahn,
2007
Marlow,
2003
McCaffery,
2003
McCaffery,
2005
McCaffery,
2006
Vanslyke,
2009
Waller,
2007b
5.5 Are findings relevant
to aims of the study?
Relevant | | | | | | | | | |
Irrelevant
Part relevant |
Ethics
6.1 Clear and coherent
reporting of ethical
considerations?
Clear | | | | | | | | | |
Unclear
Unsure/unreported |
Overall quality: G¼ good;
M¼moderately good
G M G G G M G G G G G
Table 5 Quality assessment of surveys
Daley,
2010
Ferris,
1997
Huang,
2008
Le,
2004
McCaffery,
2008
Papa,
2009
Patel,
2008
Overall clarity of aims and method:
Is the study reported in sufficient detail and clarity
for the reader to understand and make sense of it?
| | | | | | |
Selection of the sample:
Could responders be different from non-responders,
or from the population the sample was taken from?
L | | | | R R
Measurement issues:
Are the measures reported objective and reliable? | ? | | | | |
Survey methods:
Was the survey carried out in a trustworthy way? | | | | | | |
Data and statistical issues:
Was the analysis appropriately conducted? S | | S S S |
Bias
Is there evidence of any other biases (e.g., funding
bias)?
| | | | | | |
Abbreviations: L¼ low response rate (p60%); R¼ response rate not reported; S¼ small sample (p200); ?¼ scenarios were complex and questions ambiguous, representing a
potential source of bias.
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least partially to blame (McCaffery et al, 2006; Kahn et al, 2007;
Daley et al, 2010). However, some felt that guilt was not necessary
because STIs, such as HPV, are so common (McCaffery et al, 2006;
Kahn et al, 2007), or that there is no guilt attached to HPV if it is
perceived as cancer rather than an STI (Kahn et al, 2007). None of
the included surveys addressed this theme.
Reasons given for feeling guilty focused on not taking care of
oneself, not practising safe sexual behaviours, and not monitor-
ing one’s sexual partnerythey would share responsibility
because they stayed with him despite knowing he was unfaithful,
did not insist that he use a condom, or did not monitor him
carefully enough. (Kahn et al, 2007) (USA, all tested, 23%
abnormal cytology, 51% HPVþ )
Among this group of women, common STIs such as HPV were
seen as an inevitable part of sexual activity. (McCaffery et al,
2006) (UK, all tested, 54% abnormal cytology, 77% HPVþ )
Concerns about disclosure of HPV status Another issue that
added to the burden of anxiety was disclosure (McCaffery and
Irwig, 2005; McCaffery et al, 2006; Kahn et al, 2007; Waller et al,
2007b; Marlow et al, 2009; Daley et al, 2010); it was noted that the
majority of women told, or intended to tell, someone that they had
received a positive HPV test result (Kahn et al, 2007; Daley et al,
2010). The reason some participants gave was a sense of
responsibility to past, current and future sexual partners. Others
wanted support from the people they disclosed their test results to,
but this was not always possible. Where participants had disclosed
their HPV-positive status, some reported limited supportive
response because of a general lack of knowledge about the virus
(McCaffery et al, 2006; Waller et al, 2007b). Reasons women
mentioned for not disclosing their positive HPV test result
included feelings of stigma and shame, as well as feeling unable
to explain their result or not thinking it was necessary (McCaffery
et al, 2006; Kahn et al, 2007; Waller et al, 2007b). In one study,
some participants avoided talking to their partners about their
positive HPV test result by focussing instead on their smear test
result (McCaffery et al, 2006). However, it was also acknowledged
that, among couples who were open with each other about their
sexual history, disclosure did not pose problems (McCaffery et al,
2006).
For women entering new relationships testing positive led to
worries about transmitting the infection to their new partner
and anxieties about disclosing their infection to someone they
had only recently met. (McCaffery et al, 2006) (UK, all tested,
54% abnormal cytology, 77% HPVþ )
For some women feeling anxious led them to disclose their result
and this helped lessen their concerns when friends and family
were reassuring and supportive. For others disclosure was
unhelpful because friends and family had not heard of HPV and
so were not able to provide the support that had been hoped
for. (Waller et al, 2007b) (UK, normal cytology, all HPVþ at
baseline)
One US survey of women, who had tested HPV positive and who
had abnormal smear test results (Daley et al, 2010), explored
intentions to disclose their HPV status to others and found that
93% had, most commonly to a partner (39%), female friend (28%)
or their mother (18%), and 66% said they would disclose it to a
future partner. This was a small survey with a risk of response bias.
The acceptability of HPV testing and triage
Acceptability of HPV testing Questions about the acceptability
of HPV testing for women were mainly asked in hypothetical
scenarios in the qualitative studies. In five out of six of these,
participants were asked how they would feel about HPV testing if it
were available (McCaffery et al, 2003; Anhang et al, 2004; Brown
et al, 2007; Vanslyke et al, 2008; Fernandez et al, 2009). Although
most found the idea of testing acceptable, some participants
worried that the test would be embarrassing or uncomfortable,
feared the consequences of a positive outcome or, being in a
monogamous relationship, saw no need for it. There was also more
resistance to HPV testing among South Asian and Roman Catholic
groups.
For the Indian and Pakistani women, testing was perceived to
reflect non-traditional cultural or religious practices concerning
sex and monogamyy Among the White British women taboos
surrounding sex within Catholic families were also raised as
potentially restrictive to women participating in HPV testing.
(McCaffery et al, 2003) (UK, hypothetical)
The stigma associated with testing HPV positive did not
discourage them from recognising value of HPV testingyThe
desire to gain knowledge from test results and to act responsibly
outweighed the stigma attached to carrying the virus. (Brown
et al, 2007) (Canada, hypothetical)
In one hypothetical study (Brown et al, 2007), women thought
HPV testing was preferable to repeat smear tests but in another
study where HPV-positive participants had a second HPV test after
12 months (Waller et al, 2007b), most preferred the reassurance of
colposcopy to a further 12 month wait and a third HPV test.
The primary reasons for supporting this choice (HPV test) were
the convenience of a single testing visit and the reduced anxiety
involved with not having to undergo repeat cytology in 6
months. The key argument in favour of HPV testing, overall, was
a faster, more definitive result that guided them to appropriate
options. (Brown et al, 2007) (Canada, hypothetical)
Anxiety was one reason for choosing to have a colposcopy
immediatelyy There was a sense among some women that
waiting another year they might allow something to develop
which could otherwise be dealt with now. This was associated
with the belief that cancer is a disease that can progress rapidly
and therefore early detection and treatment must be important.
(Waller et al, 2007b) (UK, normal cytology, all HPVþ at
baseline)
The triage process Six included surveys sought views on HPV
triage. In one study, 968 women in US primary care were given two
case scenarios for mildly abnormal cytology. After reading
information, they were asked to choose their follow-up preferences
for each from repeat smear test, HPV test, colposcopy or
cervicography (Ferris et al, 1997). Only 7 and 8% preferred
an HPV test, but the information was complex and choices only
based on discomfort, accuracy and cost. The low risk of mild
abnormalities progressing to cervical cancer following a negative
HPV test was not explained.
In a well-conducted survey in US primary care, 865 older women
(aged 50–80 years) were asked about the acceptability of HPV
testing and its impact on their preferences for cervical screening
(Huang et al, 2008). Acceptability was high; 64% wanted to be
tested, but 78% wanted more frequent smear tests (41 annually) if
they tested positive. However, 55% of those under 65 years would
accept three yearly smear tests if they tested HPV negative and had
normal cytology, and 33% of those over 65 would be happy to stop
cervical screening altogether if they had negative results.
Two surveys recruited women in colposcopy clinics. One was a
Canadian study in which 100 women chose between two follow-up
options, either six monthly colposcopy until two consecutive
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normal examinations and cytology results (standard practice) or
HPV test and one annual colposcopy visit if HPV negative (Le et al,
2004), 64% chose the HPV test to triage the need for frequent
colposcopy follow-up. The other sought the preferences of 202 US
women after a diagnosis of grade one cervical intraepithelial
neoplasia (CIN1) between a smear test at 6 and 12 months or an
HPV test at 12 months (Patel et al, 2008). In this study, 67% said
they would feel less nervous if they could have less frequent
smears, yet 64% preferred follow-up to be a smear test at 6 and 12
months rather than an HPV test in 1 year, and 13% wanted both.
Finally, in one Australian survey, 94 women with mildly
abnormal smear test results were given a decision aid and asked
to choose between a repeat smear test (usual care) and an HPV
test; 65% chose the HPV test (McCaffery et al, 2008).
The importance of informed consent In two hypothetical
qualitative studies, where there was overall support for HPV
testing, participants mentioned the importance of informed
consent (Brown et al, 2007; Vanslyke et al, 2008). Both women
who were tested and those who were not wanted to know more
about the testing procedure (Waller et al, 2007b; Vanslyke et al,
2008; Marlow et al, 2009).
Across groups, participants spoke emphatically about the
importance of women giving express consent prior to being
tested for HPV, and said they would feel violated, tricked or
angry if they were tested without their knowledge. (Vanslyke
et al, 2008) (USA, hypothetical)
Information needs
Content and quality of information Among the qualitative
studies, women emphasised that the content and quality of
information was important and that unclear information could
be misleading and unhelpful (McCaffery et al, 2003; McCaffery and
Irwig, 2005; McCaffery et al, 2006). One study drew attention to the
difficulty people had in interpreting new information about HPV
in the context of their existing knowledge (Fernandez et al, 2009),
and in three, participants had sought information from the media,
the internet or other sources (McCaffery and Irwig, 2005; Waller
et al, 2007b; Daley et al, 2010).
It was recognised in all groups that clear and accurate
information was critical to everyone’s response to HPV and
the potential impact of testing... ‘Ignorance causes many
problems’. (McCaffery et al, 2003) (UK, hypothetical)
Throughout the discussions, participants continued to show
confusion about the new information as they attempted to fit it
into their current schemas for sexually transmitted diseases,
infection, cancer and other illness. (Fernandez et al, 2009) (USA,
hypothetical)
One US survey of 154 women who had tested HPV positive and
had abnormal smear test results (Daley et al, 2010) found that 82%
had sought information about HPV from the internet and 70%
from other sources. However, only 31% responded.
Unanswered questions Specific queries were raised in most of the
studies including questions related to HPV transmission
(McCaffery et al, 2003; Anhang et al, 2004; McCaffery and Irwig,
2005; Vanslyke et al, 2008; Fernandez et al, 2009; Marlow et al,
2009; Daley et al, 2010), prevention (Anhang et al, 2004; McCaffery
and Irwig, 2005; McCaffery et al, 2006; Vanslyke et al, 2008;
Marlow et al, 2009; Daley et al, 2010), symptoms (Anhang et al,
2004; Vanslyke et al, 2008; Fernandez et al, 2009; Marlow et al,
2009), risk factors for HPV infection and cervical cancer (Anhang
et al, 2004; Marlow et al, 2009) and whether HPV could cause other
cancers or genital warts (McCaffery et al, 2003; Anhang et al, 2004;
McCaffery and Irwig, 2005; Marlow et al, 2009).
y many asked whether HPV could be transmitted to a baby
during pregnancy or delivery. (Anhang et al, 2004) (USA,
hypothetical)
Information concerning a possible cure was sought. Some
women were curious about the preventive properties of
condoms. (Daley et al, 2010) (USA, abnormal cytology, all
HPVþ )
All women wanted to know the cause of HPV and once told it
was sexually transmitted, they asked if this was the only way to
contract ity if lifestyle factors such as diet or alcohol increased
risk of infectiony the potential for the virus to clear
spontaneously and how long this tooky(Marlow et al, 2009)
(UK, hypothetical)
Questions also arose about the natural history of HPV infection
and its progression to cervical cancer including prevalence of HPV
and cervical cancer (Marlow et al, 2009), the timeline (Marlow
et al, 2009), and latency and regression (Anhang et al, 2004;
McCaffery and Irwig, 2005; Waller et al, 2007b; Marlow et al, 2009).
In three studies participants wanted information about the
consequences of HPV infection for sexual partners (McCaffery
and Irwig, 2005; Fernandez et al, 2009; Marlow et al, 2009), and in
two of these there were also questions about the effect of HPV on
pregnancy and fertility (McCaffery and Irwig, 2005; Marlow et al,
2009).
They asked about prevalence of HPVyand wanted to know why
so many women become infectedy Women were particularly
interested in the time between contracting HPV and developing
cervical cancer yYounger women (18–25) asked many ques-
tions about the prevalence of cervical cancer... (Marlow et al,
2009)(UK, hypothetical)
Women wanted to know how long the virus could lie dormant
and whether it would ever completely clear. If women had had a
previous abnormality in the past, they wanted to know whether
this was a new infection or a recurrence of the previous
infectiony They also wanted to know what they could do about
it themselves and whether HPV could impact on their fertility.
(McCaffery and Irwig, 2005) (Australia, abnormal cytology,
all HPVþ )
Consequences for men were frequently mentioned, including
whether men were just carriers or are likely to experience
harmful effects. (Marlow et al, 2009)(UK, hypothetical)
None of the included surveys reported whether there were any
unanswered questions.
Misunderstandings and misinterpretations In several of the
qualitative studies, there was considerable confusion, misunder-
standing or misinterpretation. This was particularly apparent
in the studies where participants had not been tested for
HPV and had minimal prior knowledge (Anhang et al, 2004;
McCaffery et al, 2006; Fernandez et al, 2009; Marlow et al, 2009;
Daley et al, 2010).
A number of women tried to equate descriptions of HPV as low
risk or high risk with risky behaviours or risky individuals, as
opposed to strains of the virus. (Anhang et al, 2004) (USA,
hypothetical)
After being told that HPV caused most cases of cervical cancer,
many women interpreted the diagnosis of HPV as equivalent
to a diagnosis of cancer. (Fernandez et al, 2009) (USA,
hypothetical)
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A particular source of anxiety and confusion for many partici-
pants was the association between HPV and warts (McCaffery et al,
2003; Anhang et al, 2004; McCaffery and Irwig, 2005; McCaffery
et al, 2006; Kahn et al, 2007). People were confused about different
types of warts, where on the body they might occur and how they
were associated with different HPV types. This was compounded
by doctors’ use of the term ‘wart virus’ when referring to high-risk
HPV. Genital warts were thought to be disgusting and highly
stigmatizing, and the possibility of developing them was a source
of great distress (McCaffery et al, 2003; McCaffery and Irwig, 2005;
McCaffery et al, 2006; Kahn et al, 2007). None of the included
surveys addressed this theme.
All the women interviewed were aware of genital warts and
some thought there was an association with genital warts and
cervical cancer. Because of the greater familiarity with genital
warts and because clinicians often referred to HPV as the ‘wart
virus’, many of the women interviewed thought they had genital
warts on their cervix or elsewhere internally and were concerned
they might spread to other visible genital areas or cause warts
on their partner. (McCaffery and Irwig, 2005) (Australia,
abnormal cytology, all HPVþ )
(Some women) highlighted the negative connotations of the
term ‘wart’, which seemed to have a long-standing stigma as an
STI... ‘Warts’ in any form were viewed as unpleasant and
unwanted and these perceptions were described as being rooted
in early childhood experience. (McCaffery et al, 2003) (UK,
hypothetical)
Information that helped to reassure Some of the information
given to study participants helped to alleviate their anxiety
(McCaffery and Irwig, 2005; McCaffery et al, 2006; Waller et al,
2007b). This included that HPV is common (McCaffery and Irwig,
2005; McCaffery et al, 2006), does not have symptoms (McCaffery
et al, 2006; Waller et al, 2007b) and can be cleared by the immune
system (McCaffery and Irwig, 2005; McCaffery et al, 2006; Waller
et al, 2007b). Reassurance also came from being informed that the
transition from HPV infection to cervical cancer was slow
(McCaffery and Irwig, 2005), that there is effective treatment for
CIN (McCaffery et al, 2006; Waller et al, 2007b), and that men
rarely experience adverse effects (McCaffery et al, 2006). Women’s
distress associated with genital warts was allayed by the informa-
tion that warts were unlikely to develop (McCaffery and Irwig,
2005; McCaffery et al, 2006). Counter-intuitively the information
that condoms are only partially effective in preventing transmis-
sion of HPV was also reassuring for two reasons: it relieved
women’s sense of guilt for not using them and it removed the need
to suggest their use, which could be interpreted by a partner as
mistrust or suspicion (McCaffery et al, 2003; McCaffery et al,
2006).
Understanding that the impact of HPV on men was neg-
ligibleyappeared to alleviate considerable anxiety. Importantly
it meant that there was no necessity to inform sexual partners
about the infection, which allowed women to avoid the
challenges of disclosure. (McCaffery et al, 2006) (UK, all tested,
54% abnormal cytology, 77% HPVþ )
Information that the transition from HPV infection to cervical
cancer is slow was an important factor which reduced some
women’s anxiety about their infection. This appeared particu-
larly useful for women following observational management.
(McCaffery and Irwig, 2005) (Australia, abnormal cytology,
all HPVþ )
None of the included surveys addressed what information would
offer reassurance.
DISCUSSION
Summary of main findings
This is the first systematic review and qualitative synthesis of an
emerging international literature on people’s views about HPV
testing in the context of cervical screening. Three thematic
categories emerged: the psychosocial burden of HPV infection,
the acceptability of HPV testing and triage and information needs.
Notably, the first was much more prominent in ‘real’ situations
where participants expressed overwhelmingly negative concerns,
suggesting that facing an HPV diagnosis in real life, with the
associated problems of disclosure and fear of stigmatisation, was
more daunting than women imagined in hypothetical scenarios.
Many women in the studies of HPV testing as a hypothetical
proposal thought it a preferable alternative to repeat smear tests,
but did not want to be tested without their knowledge or without
informed consent. Our review reveals an overwhelming lack of
understanding about HPV with participants struggling to interpret
limited information in the context of existing knowledge,
impacting on the ability to make informed choices.
How this study fits in
Our findings confirm those of a review revealing poor knowledge
about HPV infection (Klug et al, 2008), inform the existing
literature on patient education and HPV suggesting the need for
simple, clear, targeted information (Waller et al, 2007a; Hall et al,
2008; Klug et al, 2008; McNair et al, 2009; Roland et al, 2009;
Waller et al, 2009; McCaffery et al, 2010), and augment the
literature on the psychological effects of testing HPV positive
(McCaffery et al, 2004; Maissi et al, 2005; Wang et al, 2010).
Study strengths and limitations
Our review was comprehensive and rigorously conducted. In
August 2011, we repeated the searches and found no new studies
meeting our inclusion criteria. There are conflicting views on what
counts as data from primary qualitative studies, and whether
original data, authors’ interpretations or both should be included
(Major and Savin-Baden, 2010). We chose to include authors’
words as they represented syntheses of complete sets of original
data of which the quotations were illustrative examples.
The review was limited by the scope of the primary studies.
There were no relevant studies exploring the views of health
professionals. Only one qualitative study and none of the surveys
recruited male participants. None of the studies developed the
theme of the impact of HPV on men, nor were there any that
investigated the views of lesbian and bisexual women. Therefore,
our review cannot reflect the views of these groups, although more
than half of the study populations included different ethnic groups.
However, there were limited comparisons between the groups and
little in-depth exploration of the related cultural influences.
Nevertheless, the rich data in the qualitative studies vividly
conveyed women’s views. However, the small number and
relatively poor quality of surveys only supplemented the qualita-
tive studies to a limited extent.
It is possible that the research itself, by raising issues for
discussion, may exacerbate anxiety; a study of women with
abnormal cervical cytology unaware of their HPV status suggested
that anxiety may be explained by factors other than learning of test
results and may vary by ethnicity and lifestyle factors (Johnson
et al, 2011). Our findings should be placed in the context of the
large number of tests having been carried out worldwide over the
past 5 years.
None of the studies investigated views about HPV triage in the
context of the UK model. Although some women may be relieved
not to have repeat smear tests, others may find the idea of not
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acting on an abnormal test result difficult. None of the studies
explored the introduction of HPV vaccination and how this would
relate to cervical screening and HPV testing. Of the 17 included
studies, only four qualitative studies and no surveys were
conducted in the United Kingdom. Therefore, the extent to which
their findings are applicable in UK settings is uncertain.
Implications for research, and UK policy and practice
More research may be needed to investigate the information needs
of women at different stages of the cervical screening processes,
and of specific groups including health professionals, HPV-
vaccinated women, ethnic minority and other hard-to-reach
groups. Women asked well-considered, thoughtfully-framed ques-
tions indicating real concern and desire to know more. Never-
theless, it is important for genuinely informed consent that people
are not overwhelmed with information (O’Neill, 2003). Identifica-
tion of the salient points allowing informed choice or uptake from
this complex information remains a challenge to researchers.
However, this review forms part of the ongoing, multi-method
HPV Core Messages Study and our findings will be aggregated with
the other study components (a systematic review of views on HPV
vaccination, qualitative interviews with UK women and girls, and
surveys of UK public and healthcare professionals) to inform the
development of educational materials.
Some terminology, for example, ‘high-risk HPV’ and ‘wart
virus’, was confusing or alarming and not clearly understood.
Explanations about causation, risk of cervical abnormality or
cancer, persistence/clearance of monogenic HPV and difference
from genital wart viruses are needed. Valuable reassuring messages
were: HPV is common, symptom free, usually clears without
treatment and rarely has adverse effects on men. Although many
women were strongly motivated to share their worries and
concerns about an HPV-positive test, some could not, because of
lack of understanding, inability to articulate their story, their
confidantes’ inability to understand, or fear of stigma or blame. It
may be helpful to emphasize the commonness of HPV so that it
becomes normalized as an everyday infection. Familiarization with
HPV through the vaccination programmed could help.
CONCLUSIONS
Faced with this new protocol, clear and consistent information and
the avoidance of ambiguous or misleading terminology could
alleviate women’s anxiety, relieve their burden of blame and allow
them informed consent. This is a substantial challenge for those
who design and provide information.
ACKNOWLEDGEMENTS
We acknowledge the contributions of Theresa Marteau, Kirsten
McCaffery and the late Joan Austoker to study design, and thank
Sally Warmington, Annie Hendry, Ellen Richards and the staff of
John Spalding Library, Wrexham Medical Institute, for their help.
This study is part of the multi-method HPV Core Messages project,
funded by Cancer Research UK (ref C1273/A9479).
Conflict of interest
The authors declare no conflict of interest.
REFERENCES
Anhang R, Wright Jr TC, Smock L, Goldie SJ (2004) Women’s desired
information about human papillomavirus. Cancer 100, pp 315–320
Barratt A, Trevena L, Davey H, McCaffery K (2004) Use of decision aids to
support informed choices about screening. BMJ 329(7464): 507–510
Bekker H (2010) Decision aids and uptake of screening: aids improve
informed decision making, but not necessarily uptake. BMJ 341: c5407
Brown L, Ritvo P, Howlett R, Cotterchio M, Matthew A, Rosen B, Murphy J,
Mai V (2007) Attitudes toward HPV testing: interview findings from a
random sample of women in Ontario, Canada. Health Care Women Int
Vol. 28, pp 782–798
Daley EM, Perrin KM, McDermott RJ, Vamos CA, Rayko HL, Packing-
Ebuen JL, Webb C, McFarlane M (2010) The psychosocial burden of
HPV: a mixed-method study of knowledge, attitudes and behaviors
among HPVþ women. J Health Psychol 15(2): 279–290
Department of Health (2011) Improving Outcomes: a Strategy for Cancer.
http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/
digitalasset/dh_123394.pdf (Accessed 12 July 2011)
Fernandez ME, McCurdy SA, Arvey SR, Tyson SK, Morales-Campos D,
Flores B, Useche B, Mitchell-Bennett L, Sanderson M (2009) HPV
knowledge, attitudes, and cultural beliefs among Hispanic men and
women living on the Texas-Mexico border. Ethn Health 14(6): 607–624
Ferris DG, Kriegel D, Cote L, Litaker M, Woodward L (1997) Women’s
triage and management preferences for cervical cytologic reports
demonstrating atypical squamous cells of undetermined significance
and low-grade squamous intraepithelial lesions. Arch Fam Med 6(4):
348–353
Hall B, Howard K, McCaffery K (2008) Do cervical cancer screening patient
information leaflets meet the HPV information needs of women? Patient
Educ Couns 72(1): 78–87
Harden A, Garcia J, Oliver S, Rees R, Shepherd J, Brunton G, Oakley A
(2004) Applying systematic review methods to studies of people’s views:
an example from public health research. J Epidemiol Community Health
58(9): 794–800
Huang AJ, Perez-Stable EJ, Kim SE, Wong ST, Kaplan CP, Walsh JME,
Iwaoka-Scott AY, Sawaya GF (2008) Preferences for human
papillomavirus testing with routine cervical cancer screening in diverse
older women. J Gen Intern Med 23(9): 1324–1329
Johnson CY, Sharp L, Cotton SC, Harris CA, Gray NM, Little J (2011)
Human papillomavirus infection and anxiety: Analyses in women with
low-grade cervical cytological abnormalities unaware of their infection
status. PLoS ONE 6(6): e21046
Kahn JA, Slap GB, Bernstein DI, Tissot AM, Kollar LM, Hillard PA,
Rosenthal SL (2007) Personal meaning of human papillomavirus and Pap
test results in adolescent and young adult women. Health Psychol 26(2):
192–200(37 ref)
Klug SJ, Hukelmann M, Blettner M (2008) Knowledge about infection
with human papillomavirus: a systematic review. Prev Med 46(2):
87–98
Le T, Hicks W, Menard C, Boyd D, Hewson T, Hopkins L, Kee Fung MF
(2004) Human papilloma virus testing knowledge and attitudes among
women attending colposcopy clinic with ASCUS/LGSIL pap smears.
J Obstet Gynaecol Canada 26(9): 788–792
Maissi E, Marteau TM, Hankins M, Moss S, Legood R, Gray A (2004)
Psychological impact of human papillomavirus testing in women with
borderline or mildly dyskaryotic cervical smear test results: cross
sectional questionnaire study. BMJ 328(7451): 1293
Maissi E, Marteau TM, Hankins M, Moss S, Legood R, Gray A (2005) The
psychological impact of human papillomavirus testing in women with
borderline or mildly dyskaryotic cervical smear test results: 6-month
follow-up. Br J Cancer 92(6): 990–994
Major CH, Savin-Baden M (2010) An Introduction to Qualitative Research
Synthesis: Managing the Information Explosion in Social Science
Research. Routledge: London
Marlow LAV, Wardle J, Grant N, Waller J (2009) Human papillomavirus
(HPV) information needs: a theoretical framework. J Fam Plann Reprod
Health Care 35(1): 29–33
McCaffery K, Forrest S, Waller J, Desai M, Szarewski A, Wardle J (2003)
Attitudes towards HPV testing: a qualitative study of beliefs among
Indian, Pakistani, African-Caribbean and white British women in the UK.
Br J Cancer 88: 42–46
Systematic review of women’s views on HPV testing
M Hendry et al
253
& 2012 Cancer Research UK British Journal of Cancer (2012) 107(2), 243 – 254
C
li
n
ic
a
l
S
tu
d
ie
s
McCaffery K, Irwig L (2005) Australian women’s needs and preferences for
information about human papillomavirus in cervical screening. J Med
Screen 12(3): 134–141
McCaffery K, Waller J, Forrest S, Cadman L, Szarewski A, Wardle J (2004)
Testing positive for human papillomavirus in routine cervical screening:
examination of psychosocial impact. BJOG 111(12): 1437–1443
McCaffery K, Waller J, Nazroo J, Wardle J (2006) Social and psychological
impact of HPV testing in cervical screening: a qualitative study. Sex
Transm Infect 82(2): 169–174
McCaffery KJ, Irwig L, Chan SF, Macaskill P, Barratt A, Lewicka M, Clarke J,
Weisberg E (2008) HPV testing versus repeat Pap testing for the
management of a minor abnormal Pap smear: evaluation of a decision
aid to support informed choice. Patient Educ Couns 73(3): 473–481
McCaffery KJ, Irwig L, Turner R, Chan SF, Macaskill P, Lewicka M, Clarke J,
Weisberg E, Barratt A (2010) Psychosocial outcomes of three triage
methods for the management of borderline abnormal cervical smears: an
open randomised trial. BMJ 340: b4491
McNair R, Power J, Carr S (2009) Comparing knowledge and perceived risk
related to the human papilloma virus among Australian women of
diverse sexual orientations. ANZ J Public Health 33(1): 87–93
Moher D, Liberati A, Tetzlaff J, Altman DG, Group FTP (2009) Preferred
reporting items for systematic reviews and meta-analyses: the PRISMA
statement. BMJ 339: 332–339
National Institute for Health and Clinical Excellence (2009) The Guidelines
Manual 2009, Appendix I: Methodology checklist: qualitative studies.
http://www.nice.org.uk/aboutnice/howwework/developingniceclinicalguidelines/
clinicalguidelinedevelopmentmethods/GuidelinesManual2009.jsp (Accessed 5
January 2011)
NHS Cancer Screening Programmes (2010) HPV Triage and Test of Cure
Protocol for Women Aged 25 to 64 Years. http://www.cancerscreening.
nhs.uk/cervical/hpv-triage-test-flowchart-v2.pdf (Accessed 14 June 2011)
NHS Centre for Reviews and Dissemination (2001) Undertaking Systematic
Reviews of Research on Effectiveness: CRD’s Guidance for those Carrying
Out or Commissioning Reviews. 2nd edn. NHS CRD, University of
York: York
NHSCSP (2010) Colposcopy and Programme Management Guidelines for the
NHS Cervical Screening Programme (2nd edition). ISBN 978 1 84463 069 1.
http://www.cancerscreening.nhs.uk/cervical/publications/nhscsp20.pdf
(Accessed 4 August 2011)
O’Neill O (2003) Some limits of informed consent. J Med Ethics 29: 4–7
Papa D, Simas TAM, Reynolds M, Melnitsky H (2009) Assessing the role of
education in women’s knowledge and acceptance of adjunct high-risk
human papillomavirus testing for cervical cancer screening. J Low Genit
Tract Dis 13(2): 66–71
Patel M, Guido R, Chang JC, Meyn LA (2008) What are patient preferences
for follow-up after low-grade cervical intraepithelial neoplasia? J Low
Genit Tract Dis 12(2): 122–126
Pettigrew M, Roberts H (2006) Systematic Reviews in the Social Sciences: a
Practical Guide. Blackwell: Oxford
Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, Britten N,
Roen K, Duffy S. Guidance on the conduct of narrative synthesis
in systematic reviews: a product of the ESRC methods programme
(Version I) (available from n.simpson@lancaster.ac.uk). Lancaster:
Institute of Health Research, 2006
Ritchie J, Spencer L (1994) Qualitative data analysis applied policy research.
In Analysing Qualitative Data, Bryman A, Burgess R (eds) pp 173–194.
Routledge: London
Roland KB, Benard VB, Saraiya M, Hawkins NA, Brandt H, Friedman AL
(2009) Assessing cervical cancer screening guidelines in patient
education materials. J Women’s Health 18(1): 5–12
Swallow V, Newton J, Lottum CV (2003) How to manage and display
qualitative data using ’Framework’ and Microsofts Excel. J Clin Nurs 12:
610–612
Vanslyke JG, Baum J, Plaza V, Otero M, Wheeler C, Helitzer DL (2008)
HPV and cervical cancer testing and prevention: knowledge, beliefs,
and attitudes among Hispanic women. Qual Health Res 18(5):
584–596
Waller J, Marlow LAV, Wardle J (2007a) The association between
knowledge of HPV and feelings of stigma, shame and anxiety. Sex
Transm Infect 83(2): 155–159
Waller J, Marlow LAV, Wardle J (2009) Anticipated shame and worry
following an abnormal Pap test result: The impact of information about
HPV. Prev Med 48(5): 415–419
Waller J, McCaffery K, Kitchener H, Nazroo J, Wardle J (2007b) Women’s
experiences of repeated HPV testing in the context of cervical cancer
screening: a qualitative study. Psycho-Oncol 16: 196–204
Wang K-L, Jeng C-J, Yang Y-C, Chen C-A, Cheng W-F, Chen T-C, Mast TC,
Wang Y-C, Hsieh C-Y (2010) The psychological impact of illness among
women experiencing human papillomavirus-related illness or screening
interventions. J Psychosom Obstet Gynaecol 31(1): 16–23
APPENDIX 1
Search strategy
Databases searched
 MEDLINE
 MEDLINE in process and other non-indexed citations
 EMBASE
 CINAHL (Cumulative Index to Nursing and Allied Health Literature)
 PsycINFO
 AMED (Allied and Complementary Medicine Database)
 HMIC (Health Management Information Consortium)
 BNI (British Nursing Index)
 Cochrane library
 BIOSIS
 SCI (Science Citation Index)
 SSCI (Social Science Citation Index)
 ISI proceedings
 ASSIA (Applied Social Sciences Index and Abstracts)
Search Strategy for Medline (adapted for other databases)
1. Papillomavirus Vaccines/
2. DNA Probes, HPV/
3. Human papillomavirus 16/
4. Human papillomavirus 18/
5. (HPV).ti,ab.
6. (Human papilloma viru$).ti,ab.
7. (Human papillomaviru$).ti,ab.
8. (vaccin$ or immunis$).ti,ab.
9. (prevent or prevention or preventing).ti,ab.
10. (test or testing).ti,ab.
11. 1 or 2 or 3 or 4 or 5 or 6 or 7
12. 8 or 9 or 10
13. 11 and 12
14. 13 limited to human
15. 16 limited to 1980 onwards
16. (L1 or E2 or E5 or E6 or E7).ti,ab.
17. 15 not 16
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